Charles River Labs

Charles River Laboratories International is an American biotechnology company headquartered in Wilmington, Massachusetts, United States. Founded in 1947 by Henry Foster as a provider of laboratory animal models, it has evolved into a global leader in preclinical and clinical services for pharmaceutical, biotechnology, and medical device industries. The company's segments lude Research Models and Services, offering rodents and genetic research tools; Discovery and Safety Assessment, providing drug discovery and toxicology testing; and Manufacturing Solutions, encompassing biologics production and microbial testing. Charles River operates over 150 facilities in 21 countries, serving clients through integrated services from target identification to market approval, with partnerships for cell and gene therapy development. Its operations involve global suppliers for feed and equipment, adhering to GLP, ISO, and AAALAC standards for animal welfare and data integrity. The firm invests in AI for pathology and sustainable practices like water recycling. In 2024, Charles River reported revenues of $4.2 billion, a 2% rease, driven by demand for oncology and gene therapy services.